Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
HELP
Stock Latest News
Company Announcements
Helus Pharma CEO to Spotlight Late-Stage Mental Health Pipeline at Cantor Conference
2d ago
HELP
Premium
The Fly
Psychedelic: Enveric, Helus, Bright Minds report earnings results
15d ago
LLY
ATAI
Premium
The Fly
Helus Pharma price target raised to $62 from $8 at TD Cowen
16d ago
HELP
Premium
Ratings
Helus Pharma: Buy Rating Reaffirmed as Phase 3 MDD Program Advances; $70 Price Target Maintained
17d ago
HELP
Premium
Company Announcements
Helus Pharma Bolsters Leadership with Key HR and CNS Drug-Development Appointments
18d ago
HELP
Premium
The Fly
Helus Pharma appoints Regina Donohue as chief people officer
18d ago
HELP
Premium
Company Announcements
Helus Pharma Posts Larger Quarterly Loss as R&D Spend Jumps, Backed by Strong Cash Reserves
22d ago
6K
HELP
Premium
Company Announcements
Helus Pharma CEO to Spotlight Mental Health Pipeline at Canaccord Growth Conference
25d ago
HELP
Premium
The Fly
Psychedelic: Compass Pathways, GH Research report quarterly earnings
29d ago
CMND
CMPS
Premium
The Fly
Helus Pharma appoints Michael Halstead as CEO
1M ago
HELP
Premium
Company Announcements
Helus Pharma Names Former Intra-Cellular President Michael Halstead as CEO Amid Phase 3 MDD Push
1M ago
6K
HELP
Premium
The Fly
Psychedelic: Clearmind reports safety findings for CMND-100
1M ago
CMND
CMPS
Premium
The Fly
Helus Pharma initiated with an Overweight at Wells Fargo
1M ago
HELP
Premium
The Fly
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
1M ago
LLY
ATAI
Premium
Ratings
Helus Pharma: Late-Stage Psychedelic Depression Data Seen as Near-Term Catalyst; Buy Rating Reaffirmed with Unchanged $70 Target
1M ago
HELP
Premium
Company Announcements
Helus Pharma Fast-Tracks Phase 3 Enrollment for MDD Drug HLP003
2M ago
6K
HELP
Premium
The Fly
Helus Pharma completes enrollment in Phase 3 APPROACH study of HLP003
2M ago
HELP
Premium
The Fly
Helus Pharma price target lowered to $45 from $48 at Guggenheim
2M ago
LLY
ATAI
Premium
Company Announcements
Helus Pharma Raises US$50 Million to Advance Novel Mental Health Pipeline
2M ago
6K
HELP
Premium
The Fly
AtaiBeckley downgraded to Hold from Buy at JonesResearch
2M ago
ATAI
CMPS
Premium
The Fly
FDA announces availability of final guidance for psychedelic drug research
2M ago
ATAI
CMND
Premium
The Fly
Helus Pharma price target lowered to $15 from $30 at Alliance Global
2M ago
HELP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
